跳至主要内容
临床试验/NCT03962127
NCT03962127进行中(未招募)不适用

MIDNOR-STROKE A Prospective Observation Study of a Cohort of 800 Patients With First Ever Ischemic Stroke in Central Norway

Norwegian University of Science and Technology8 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2015年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
800
试验地点
8
主要终点
Mortality after first ischemic stroke

研究概览

简要总结

Annually 13000 Norwegians experience an ischemic stroke. The number of stroke is anticipated to increase with 50% within 2030 due to a growing number of elderly. Many of them will have severe function deficits and reduced quality of life. The investigators have established a cohort consisting of 800 patients with first time ischemic stroke treated at hospitals in Central Norway. The investigators want to study the incidence and prognostic markers for death, recurrent stroke and severe functional deficits during a period of 10 years after the initial ischemic stroke. The investigators want to focus on the impact of physical functioning, the level of physical activity and use of medication for secondary prevention on the incidence of death, recurrent stroke and severe functional deficits. The investigators are especially interested in the importance of fulfilling the treatment targets for blood pressure and cholesterol and the importance of smoking cessation in stroke survivors. Our objective is to improve todays stroke treatment and achieve a more efficient use of the health resources in order to increase survival after stroke maintaining a good physical and psychological function and quality of life.

详细描述

MIDNOR STROKE is a descriptive prospective longitudinal cohort study, which includes patients with a first event of ischemic stroke admitted to hospitals in Central Norway. The overall objective of this study is to complete a 10-year follow-up of patients with ischemic stroke.

Patient recruitment started 01.09.2015 and ended 01.11.2017. During this time-period, a total of 802 patients were recruited. Patient follow-up at 3 months is completed and follow-up at 12 months will be completed 01.11.18.

All participants met the following inclusion criteria; cerebral infarction according to ICD-10 CM code I63, > 18 years of age, first time stroke, resident in Central-Norway and recruited within a timeframe of 7 days of hospital admission. Patients were excluded if focal neurological symptoms turned out to be not stroke-related or if there were significant physical disabilities prior to stroke (defined as Modified Rankin ≥5)

Eligible stroke patients were recruited during acute stay in hospital. Written informed consent was obtained from all potential stroke patients and from their legal caretakers (mostly a close family member), admitted to the hospital and each subject signed an informed consent form. All participants were examined and treated in line with The Recommended Guidelines for treatment and rehabilitation of stroke, which includes clinical examinations, blood tests, assessment of risk profile and additional relevant examinations.

Stroke patients were recruited and patient data collected by a designated nurse during the initial stay at the hospital. Either a nurse or research assistant in the project performed patient follow-up at 3 and 12 months. Data collected at 3 months included data from a clinical and physical assessment, interview, questionnaires and medical records. Follow-up data at 12 months is collected by phone interview and questionnaires.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Cerebral infarction according to ICD-10 CM code I63
  • •> 18 years of age
  • •First time stroke resident in Central-Norway
  • •Recruited within a time frame of 7 days of hospital admission.

排除标准

  • •Focal neurological symptoms turned out to be not stroke-related
  • •Significant physical disabilities prior to stroke (defined as Modified Rankin ≥5).

研究组 & 干预措施

First time ischemic stroke

Patients with a first event of ischemic stroke admitted to hospitals in Central Norway.

干预措施: no intervention (Other)

结局指标

主要结局

Mortality after first ischemic stroke

时间窗: 3 months

Measured with data from Norwegian Death Registry

The incidence of recurrent stroke after first ever ischemic stroke

时间窗: 3 months

Measured by using data from the Norwegian Stroke Registry and other Norwegian Cardiovascular registries including patient questionnaires

The incidence of recurrent stroke after first ever ischemic stroke

时间窗: 1 year

Measured by using data from the Norwegian Stroke Registry and other Norwegian Cardiovascular registries including patient questionnaires

The incidence of recurrent stroke after first ever ischemic stroke

时间窗: 3 years

Measured by using data from the Norwegian Stroke Registry and other Norwegian Cardiovascular registries including patient questionnaires

The incidence of recurrent stroke after first ever ischemic stroke

时间窗: 5 years

Measured by using data from the Norwegian Stroke Registry and other Norwegian Cardiovascular registries including patient questionnaires

Mortality after first ischemic stroke

时间窗: 1 year

Measured with data from Norwegian Death Registry

Mortality after first ischemic stroke

时间窗: 3 years

Measured with data from Norwegian Death Registry

Mortality after first ischemic stroke

时间窗: 5 years

Measured with data from Norwegian Death Registry

Functional disability after stroke

时间窗: 3 months after stroke

Modified rankin scale 3 - 5 (the degree of disability, total range 0 - 6, value above 2 represents a worse outcome)

Functional disability after stroke

时间窗: 1 year after stroke

Modified rankin scale 3 - 5 (the degree of disability, total range 0 - 6,value above 2 represents a worse outcome)

Functional disability after stroke

时间窗: 3 years after stroke

Modified rankin scale 3 - 5 (the degree of disability, total range 0 - 6, value above 2 represents a worse outcome)

Functional disability after stroke

时间窗: 5 years after stroke

Modified rankin scale 3 - 5 (the degree of disability, total range 0 - 6, value above 2 represents a worse outcome)

Health-related quality of life after stroke

时间窗: 3 months after stroke

EQ-5D-5L (5 Levels from 1-5 in 5 categories where values above 2 represents reduced life quality)

Health-related quality of life after stroke

时间窗: 1 year after stroke

EQ-5D-5L(5 Levels from 1-5 in 5 categories where values above 1 represents reduced life quality)

Health-related quality of life after stroke

时间窗: 3 years after stroke

EQ-5D-5L(5 Levels from 1-5 in 5 categories where values above 1 represents reduced life quality)

Health-related quality of life after stroke

时间窗: 5 years after stroke

EQ-5D-5L (5 Levels from 1-5 in 5 categories where values above 1 represents reduced life quality)

The incidence of recurrent stroke after first ever ischemic stroke

时间窗: 10 years

Measured by using data from the Norwegian Stroke Registry and other Norwegian Cardiovascular registries including patient questionnaires

Mortality after first ischemic stroke

时间窗: 10 years

Measured with data from Norwegian Death Registry

Functional disability after stroke

时间窗: 10 years after stroke

Modified rankin scale 3 - 5 (the degree of disability, total range 0 - 6, value above 2 represents a worse outcome)

Health-related quality of life after stroke

时间窗: 10 years after stroke

EQ-5D-5L (5 Levels from 1-5 in 5 categories where values above 1 represents reduced life quality)

次要结局

  • Proportion of patients reaching secondary prevention targets(3 months, 1, 3, 5 and 10 years)
  • Cost-benefit analysis(1, 5 and 10 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

MIDNOR-STROKE- a Long Term Follow-up Study of... | 临床试验